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Hormaomycin produced by Streptomyces griseofla-
vus is a structurally highly modified depsipeptide
that contains several unique building blocks with
cyclopropyl, nitro, and chlorine moieties. Within the
genus Streptomyces, it acts as a bacterial hormone
that induces morphological differentiation and the
production of bioactive secondary metabolites.
In addition, hormaomycin is an extremely potent
narrow-spectrum antibiotic. In this study, we shed
light on hormaomycin biosynthesis by a combination
of feeding studies, isolation of the biosynthetic nonri-
bosomal peptide synthetase (NRPS) gene cluster,
and in vivo and in vitro functional analysis of enzymes.
In addition, several nonnatural hormaomycin conge-
ners were generated by feeding-induced metabolic
rerouting. TheNRPScontains numeroushighly repet-
itive regions that suggest an evolutionary scenario for
this unusual bacterial hormone, providing new
opportunities for evolution-inspired metabolic engi-
neering of novel nonribosomal peptides.
INTRODUCTION
Streptomycetes, an exceptionally rich bacterial source of natural
products, employ a complex network of signaling factors to
regulate their secondary metabolism (Bibb, 2005; Rokem et al.,
2007). While most of the identified signals are intracellular
proteins, a small number of low-molecular weight compounds
have been identified that diffuse away from the producer and
trigger biosynthetic and morphological events at more remote
locations in the bacterial community (Horinouchi and Beppu,
1994; Igarashi et al., 2001; Kondo et al., 1987; Recio et al.,
2004; Takano, 2006). These substances (Figure 1) exhibit diverse
structures, the most unusual being displayed by hormaomycin
(1) (Reinscheid et al., 2006; Ro¨ssner et al., 1990; Zlatopolskiy
et al., 2004), also known as takaokamycin (Omura et al., 1984).Chemistry & Biology 18, 3At nanomolar concentrations, this depsipeptide stimulates the
production of antibiotics and the formation of aerial mycelium
in various actinomycetes (Andres et al., 1989, 1990). In addition
to the interspecies hormonal activity, 1 exhibits extremely potent
narrow-spectrum antibiotic activities against coryneform actino-
mycetes (lowest measured MIC value 88 pM) (Andres et al.,
1990). To date, the molecular mechanisms underlying these
diverse activities are unknown.
The structure of 1, which has been confirmed by total
synthesis (Zlatopolskiy and de Meijere, 2004), is unique among
signaling metabolites. It contains several unprecedented resi-
dues with chlorine, nitro, and cyclopropyl moieties in addition
to a single proteinogenic amino acid, L-Ile. To date, limited infor-
mation on the biosynthesis of only one residue exists. Feeding
studies established that the 3-(trans-20-nitrocyclopropyl)alanine
([3-Ncp]Ala [5]) unit is derived from L-lysine (Brandl et al., 2004)
via functionalization of the g-position and oxidation of the
u-amino group, but the individual enzymatic steps leading to
this amino acid are unknown. Feeding studies also revealed
that various analogs of amino acids can be readily incorporated
into 1 (Kozhushkov et al., 2005; Zlatopolskiy et al., 2006) and
demonstrated that this approach can result in dramatic changes
of the pharmacological profile (Zlatopolskiy et al., 2006). In
particular, hormaomycin D2 containing a 5-nitronorvaline residue
at one (3-Ncp)-Ala site exhibits a high antifungal activity against
Candida albicans, while 1 itself is completely inactive. These data
suggest an inherent catalytic flexibility of the biosynthetic
machinery that could be exploited by metabolic engineering
and mutasynthesis to generate novel bioactive peptides. To
provide the foundation for such studies and obtain deeper
insights into the biosynthesis of 1, we report here feeding exper-
iments, precursor-directed biosynthesis studies, isolation of the
biosynthetic gene cluster and in vivo and in vivo functional exper-
iments on several genes that reveal new insights into the
assembly of this unique peptide.
RESULTS AND DISCUSSION
Identification of the Biosynthetic Precursors
To obtain information about the biosynthesis of residues
other than (3-Ncp)Ala (5), incubation experiments with candidate81–391, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 381
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Figure 1. Selected Representatives of
Major Structural Families of Bacterial
Hormones
Hormaomycins J1-J3 are artificial analogs of the
natural product hormaomycin (1) that were gener-
ated in this study. See also Figure S2, Tables S1
and S2 and Supplemental Experimental Methods.
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Hormaomycin Biosynthesisprecursors were conducted. Pyrrole-2-carboxylic acid units
related to Chpca (6) are found in several other natural products,
such as aminocoumarins, phenalinolactone, pyoluteorin, and
prodiginins (Walsh et al., 2006). They are often derived from
proline via covalent attachment to a peptidyl carrier protein
(PCP) and dehydrogenase-catalyzed aromatization. Therefore,
a liquid culture of S. griseoflavus was supplemented with
2.2 mM L-[1-13C]Pro. After isolation of hormaomycin, its
13C-NMR spectrum showed 15.3% specific enrichment at the
carbonyl signal of the Chpca (6) moiety, thus suggesting
a biosynthesis from Pro (see Table S1 available online). In
contrast, no enrichment of the (4-Pe)Pro (7) signals was
observed, which argued against proline being a precursor of
this amino acid. The biosynthetic origin of (b-Me)Phe (8) was
probed by feeding stable isotope-labeled L-Phe and L-Met. The
presence of 3 mM L-[1-13C]Phe in the cultivation medium
resulted in strong isotope enrichments at the corresponding
positions of the two 8 residues (45.3% for (b-Me)Phe I,
d = 169.7 ppm, and 42.0% for (b-Me)Phe II, d = 170.8 ppm).
Even higher enrichments resulted from feeding with 1 mM
L-[methyl-13C]Met, which can serve as a methyl donor in
S-adenosylmethionine (SAM)-dependent biological methyla-
tions. Here, 61.6% and 70.7% of the label were incorporated
into the methyl groups of (b-Me)Phe I (d = 13.3 ppm) and
(b-Me)Phe II (d = 17.7 ppm), respectively. The (b-Me)Phe units
should therefore be derived from Phe or a related compound,
which is methylated by a SAM-dependent methyltransferase.
In the feeding studies using labeled Met, we observed an
additional enhanced carbon signal at d = 13.2 ppm, which
belongs to the terminal methyl group of (4-Pe)Pro (7). A similar
incorporation pattern was previously reported for structurally
related moieties in lincomycin (Brahme et al., 1984), and pyr-
rolo[1,4]benzodiazepines (Hurley, 1980). These originate from
L-Tyr via a poorly characterized pathway involving cleavage
of the oxidized intermediate L-DOPA (13). To test whether a
similar route provides the 7 unit in hormaomycin biosynthesis,
L-[1-13C]Tyr was administered to cultures of the producer strain382 Chemistry & Biology 18, 381–391, March 25, 2011 ª2011 Elsevier Ltd All rights reservedat 2.8 mM concentration. This resulted in
an isotope enrichment at the amide
carbon of 7 (63.0% at d = 61.4 ppm).
In addition, hormaomycin isolated from
another culture containing 2.8 mM
L-[5,6,8,9-2H4]Tyr showed an incorpora-
tion of three of the four deuterium labels
into 7, as judged from a depletion of the
corresponding proton NMR signals.
These data are in agreement with the
loss of one deuterium by hydroxylation
of this precursor to 13.Finally, feeding of [1-13C]-Ile (2 mM) resulted in an enhanced
signals for C-1 of the Ile moiety (43.2%), while feeding of
DL-[1-13C]- Thr (3 mM) resulted in a high enrichment of C-1 of
the D-allo-Thr (88.6%) and additionally the Ile (11.5%) unit in 1.
Isolation of the Hormaomycin Biosynthetic GeneCluster
As a basis formolecular studies, a pWEB-based cosmid library of
S. griseoflavus W-384 genomic DNA was prepared. One thou-
sand clones were subjected to several rounds of screening by
Southern hybridization. Since the structure of 1 suggested
biosynthesis by a nonribosomal peptide synthetase (NRPS)
(Sieber and Marahiel, 2005), we initially screened the library
with a heterologousNRPSgeneprobederived from the friulimicin
gene cluster of Actinoplanes friuliensis (Mu¨ller et al., 2007). This
analysis yielded cosmids covering three distinct genomic
regions, as judged from the restriction patterns, indicating the
presence of more than one NRPS cluster. To differentiate
between these loci, anadditional probederived fromthehalogen-
ase gene cloN3 of the clorobiocin pathway (Pojer et al., 2002)
was used to target genes involved in the formation of the
chlorinated building block Chpca (6). Hybridizing bands were
obtained for onlyoneof thecosmidgroups, ofwhich the twoover-
lapping cosmids pHR6G10 and pHR1F4 were sequenced.
The analysis revealed a 48,409 bp region of 23 clustered ORFs,
designated as hrm genes, as candidates for hormaomycin (1)
biosynthesis (Figure 2 and Table 1). The gene cluster consists
of two giant NRPS genes surrounded by smaller ORFs related
to genes involved in precursor biosynthesis, regulation and trans-
port. Adjacent in the upstream and downstream directions we
found close homologs to the genes SCO1544-SCO1553 from
Streptomyces coelicolor. Except for the presence of the hrm
system between the SCO1551 and SCO1552 counterparts, the
genes are perfectly syntenous in both bacteria, suggesting that
the hrm cluster has been inserted between the SCO1551 and
SCO1552 orthologs in the 1 producer. The boundaries of the
hrm system are therefore most likely represented by hrmA and
hrmW.
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Figure 2. Genes and Enzymes Involved in
Hormaomycin Biosynthesis
(A) Map of the hrm biosynthetic gene cluster. The
SCO labels above the genes shown in black refer
to close homologs present in the Streptomyces
coelicor genome.
(B) Biosynthetic model for peptide assembly. The
small circles represent PCP domains. Numbers
refer to the start of individual modules.
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Hormaomycin BiosynthesisThe presence of eight building blocks in 1 is perfectly mirrored
by the NRPS architecture. In total, we identified eight homologs
of peptidyl carrier proteins (PCPs), which covalently bind the
building blocks during peptide biosynthesis. One of these is en-
coded by the free-standing gene hrmL, and seven are integrated
into the NRPS modules of the large proteins HrmO and HrmP. A
bioinformatic analysis of the recognition motifs of the amino
acid-activating adenylation domains (A domains), which can
provide information on their substrate specificities (Challis
et al., 2000; Stachelhaus et al., 1999), suggested Thr being incor-
porated by module 2 and Val or Ile by module 6, in agreement
with the structure of 1 (Table 2). In contrast, the motifs of the re-
maining modules, which recognize unusual amino acids, are to
our knowledge novel. In addition, HrmK resembles a free
standing A domain with a nonribosomal code that is 80% iden-
tical to the code of the Proactivating enzyme PltF, suggesting
a possible role in starter unit biosynthesis. Also in line with the
peptide structure, epimerase domains that normally generate
D-configured amino acids are present on modules 2 and 4.
According to their location, these should generate the D-allo-
Thr and D-(3-Ncp)Ala residues.Chemistry & Biology 18, 381–391, March 25, 2011A striking feature of hrmO and hrmP,
which severely complicated sequenc-
ing, was the high similarity between
numerous DNA regions (Figure 3A).
Particularly high nucleotide identities
exceeding 90% exist between modules
expected to incorporate identical amino
acids, i.e., between modules 1 and 4 of
hrmO (predicted: [3-Ncp]Ala[(5]) and
between module 3 of hrmO and module
1 or hrmP (predicted: [b-Me]Phe [8]).
Remarkably, however, even some A
domains that activate different amino
acids are closely related to each other.
Particularly striking examples are the
domain pairs specific for 5 and 8, which
exhibit 91% nucleotide identity except
for an approximately 420 bp region
immediately downstream of a conserved
translated YTSGS motif (Figure 3B).
Intriguingly, this region almost precisely
corresponds to the amino acid recogni-
tion pocket previously identified in struc-
tural studies (Conti et al., 1997). These
features provide direct insights into the
evolution of NRPS systems, suggesting
a scenario in which new NRPS function-ality can already arise by recombinatorial exchange of only short
DNA stretches covering the specificity region, in addition to the
previously observed exchanges of entire modules (Rounge
et al., 2008), A domains (Fewer et al., 2007; Ishida et al., 2009),
or multiple regions (Tooming-Klunderud et al., 2008).
To examine the function of the NRPS, the adenylation domain
region of hrmP1, which was suspected to be specific for b-Me-
Phe (8), was amplified by PCR and cloned into the expression
vector pHIS8. After overexpression of the octahistidine-tagged
protein in Escherichia coli BL21(DE3), soluble enzyme was
obtained and purified with Ni-NTA affinity chromatography (Fig-
ure 4A). The desalted 58 kDa protein was analyzed using a
recently published nonradioactive adenylation assay based
on pyrophosphate isotope exchange in [g-18O4]-ATP (Phelan
et al., 2009). After incubating the protein with various amino
acid test substrates, analysis of the products by MALDI-TOF
MS showed the highest exchange rate with b-Me-Phe, as
expected from the position of the A domain in the NRPS (Fig-
ure 4B; Figure S1). Since the sequences of the HrmP1 and
HrmO3 A domains are virtually identical, the latter should exhibit
the same activity.ª2011 Elsevier Ltd All rights reserved 383
Table 1. Deduced Proteins Encoded on the hrm Region and Their Putative Functions
Protein
Amino
Acids Proposed Function Sequence Similarity (protein, origin) Similarity/Identity
Accession
Number
HrmA 321 AraC-type transcriptional regulator SCO0287, Streptomyces coelicolor 84/75 CAB54172
HrmB 197 Putative regulator NovE, Streptomyces spheroides 73/60 AAF67498
HrmC 358 Methyltransferase LmbW, Streptomyces lincolnensis 72/57 CAA55769
HrmD 298 F420-dependent oxidoreductase SCO3591, S.coelicolor 63/52 CAA22223
HrmE 326 Tyrosine hydroxylase LmbB2, S. lincolnensis 55/47 CAA55748
HrmF 185 DOPA-cleaving oxidoreductase TomH, Streptomyces achromogenes 69/61 ACN39014
HrmG 599 g-Glutamyltranspeptidase LmbA, S. lincolnensis 73/64 CAA55746
HrmH 132 Putative regulator YjgH, Kineococcus radiotolerans 80/60 YP_001362405
HrmI 350 Unknown PSPTOT1_5436, Pseudomonas syringae
pv. tomato
72/57 ZP_03398257
HrmJ 227 Unknown PSPTOT1_5436, P. syringae pv. tomato 70/51 ZP_03398257
HrmK 527 Acyl-CoA synthetase CLOSCI_02396, Clostridium scindens 57/39 ZP_02432136
HrmL 91 Type II peptidyl carrier protein VinL, S. halstedtii 59/40 BAD08369
HrmM 388 Acyl-CoA dehydrogenase MoeH5, Streptomyces clavuligerus 51/33 YP_002190358
HrmN 389 Acyl-CoA dehydrogenase Strop_4265, Salinispora tropica 49/36 YP_001161071
HrmO 5252 NRPS (C A PCP C A PCP E C A PCP
C A PCP E)
RHA1_ro00141, Rhodococcus sp. RHA 40-60%
domain identity
YP_700135
HrmP 3471 NRPS (C A PCP C A PCP C A PCP TE) SACE_4287, Saccharopolyspora erythraea 40-60%
domain identity
YP_001106481
HrmQ 448 Halogenase Pyr29, Actinosporangium vitaminophilum 78/65 ABO15865
HrmR 72 MbtH homolog SCO3218, S. coelicolor 81/58 CAB38589
HrmS 329 Methyltransferase MppJ, Streptomyces hygroscopicus 67/52 AAU34201
HrmT 301 Diaminopimelate epimerase DAPF2 (SAV3161), S. avermitilis 63/47 BAB69347
HrmU 427 Integral membrane antitransporter CZA382.28, Amycolatopsis orientalis 68/56 CAB45049
HrmV 224 ABC transporter ATP binding protein A20C1_11161, marine actinobacterium
PHSC20C1
56/38 ZP_01130568
HrmW 563 Integral membrane protein JNB_10189, Janibacter sp. HTCC2649 38/26 ZP_00994281
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In agreement with the feeding studies, the hrm system contains
the clustered genes hrmKLM, homologs of which are found in
various gene clusters for pyrrole carboxylic acid derivatives
(Walsh et al., 2006). The nonribosomal code of HrmK indicates
that it attaches Pro to a PCP, for which HrmL is a good candidate
(Figure 5A). HrmM is closely related to dehydrogenases cata-
lyzing the four-electron oxidation of prolyl-PCP to generate
2-pyrroloyl-PCP (Garneau et al., 2005; Garneau-Tsodikova
et al., 2006). The adjacently encoded HrmN is also distantly
related to these enzymes and might also participate in prolineTable 2. Analysis of the Specificity-Conferring Residues in the hrm
Domain Nonribosomal Code Closest Re
HrmK DLFYAAKVCK DLLYAALV
HrmO1/O4 DPIVVGGVAK n.h.a
HrmO2 DFWNIGMVHK DFWNIGM
HrmO3/P1 DAWTTAVAAK n.h.
HrmP2 DGYFWGVTFK DAYFWGV
DGFFFGVV
HrmP3 DVQFSAHGAK n.h.
a No significant hit in database searches.
384 Chemistry & Biology 18, 381–391, March 25, 2011 ª2011 Elseviearomatization. Chlorination is performed by HrmQ, which is
highly similar to Pyr29 and PltA, enzymes in the pyrrolomycin
and pyoluteorin pathway that chlorinate pyrrole moieties
(Dorrestein et al., 2005; Zhang and Parry, 2007). Insights into
its function came from recent combinatorial expression of
hrmQ with genes of the clorobiocin gene cluster, which led to
production of hybrid aminocoumarins with an additional chlorine
atom at position 5 of the pyrrole unit, thus suggesting its role
in Chpca (6) biosynthesis (Heide et al., 2008). A gene responsible
for the N-hydroxylation was not directly obvious from the
sequence data.A Domains
lated Code (A domain) Specificity of Related Domain
CK (PltF) Pro
—
VHK (SypC5) Thr
—
TFK (AcmB2)
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Figure 3. Similarity Analysis of Hormaomycin NRPS Components
(A) Dot plot analysis of the NRPS genes hrmO and hrmP (lines show region with
at least 90% nucleotide identity).
(B) Amino acid conservation plot of the A domains of modules HrmO1 (specific
for [3-Ncp]Ala) and HrmP1 (specific for [3-Me]Phe). The arrows mark the spec-
ificity-conferring residues that constitute the nonribosomal code (Challis et al.,
2000; Stachelhaus et al., 1999).
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(B) Degree of exchange in the [g-18O4]-ATP assay with various test substrates,
as measured by MALDI-TOF MS.
See also Figure S1.
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Hormaomycin BiosynthesisSince pyrrole-2-carboxylic acid (14), tethered to the PCP
HrmL, is a likely precursor of 1, we tested whether peptide yields
can be increased by addition of 14 to the cultivation medium.
After initial growth of a culture for 24 hr, 14 was added over
a period of 10 hr to a final concentration of 2 mM. This treatment
resulted in the production of up to 45mg L-1 1, which is the 4-fold
yield of a typical culture without added precursor. As this
result suggested an efficient incorporation into 1, we next
examined whether novel hormaomycins can be obtained by
feeding nonnatural analogs of 14. However, after addition of
furfuric, thiophene-2-carboxylic, tetrahydrofurane-2-carboxylic,
picolinic, pipecolinic or 3-chlorosalicylic acid, only authentic
hormaomycin was detected with isolated yields being identical
to untreated cultures. The loading and/or extension enzymes
of the hormaomycin assembly line therefore seem to exhibit
a high selectivity for the starter unit.(b-Me)Phe Biosynthesis
According to the feeding studies, the methyl group of (b-Me)Phe
(8) is introduced by a SAM-dependent methyltransferase.
An analysis of the gene cluster revealed two methyltransferase
gene candidates hrmC and hrmS present on cosmids pHR6G10
and pHR1F4, respectively. Amino acids carrying a b-methylation
are components of several nonribosomal peptides. 8 orChemistry & Biology 18, 3derivatives are also incorporated in the sponge-derived
metabolite theonegramide (Bewley and Faulkner, 1994) and
the mannopeptimycin antibiotics (Magarvey et al., 2006). The
mannopeptimycin gene cluster contains the close hrmS
homolog mppJ, the deletion of which led to the production of
a linear peptide carrying an unmethylated Phe residue (Magar-
vey et al., 2006). This suggests that HrmS is involved in the
biosynthesis of 8 (Figure 5B). Studies on the lipopeptide antibi-
otics CDA, daptomycin and A54145 demonstrated that their
common 3-methylglutamate residue is formed by methylation
of a-ketoglutarate and subsequent amination (Mahlert et al.,
2007). The latter reaction is catalyzed by IlvE, an aminotrans-
ferase from primary metabolism. As the hormaomycin gene
cluster lacks a recognizable aminotransferase gene, amination
by a housekeeping enzyme is also likely for (b-Me)Phe biosyn-
thesis, indicating that Streptomyces spp. contain one or
several promiscuous aminotransferases for the generation of a
substantial number of nonproteinogenic amino acids. To test
whether residues other than 8 can be incorporated at the two
hormaomycin sites, we fed various analogs of this amino acid
to liquid cultures of S. griseoflavus. Addition of L-Tyr or phenyl-
glycine did not result in a change of the metabolic profile. After
feeding of racemic o-fluorophenylalanine or its meta isomer,
7.7 and 17.8 mg, respectively, of isomeric mixtures of hormao-
mycins were isolated that could not be separated further by81–391, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 385
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Figure 5. Biosynthetic Models for Amino
Acid Pathways in Hormaomycin Biosyn-
thesis
(A) Proposed biosynthesis of Chpca (6).
(B) Proposed biosynthesis of (b-Me)Phe (8).
(C) Possible scenario for the biosynthesis of
(4-Pe)Pro (7). Enzyme homologs from the linco-
mycin (lmb), anthramycin (ORFxy), sibiromycin
(sib), and tomaymycin (tom) pathways are also
shown. Proteins in parentheses were proposed
to convert variants of the substrates shown.
(D) Proposed biosynthesis of (3-Ncp)Ala (5).
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Hormaomycin Biosynthesischromatography. MS analysis by negative ion electrospray ioni-
zation (ESI) revealed in both mixtures the presence of two new
compounds with the ions m/z = 1145 and 1163 [M-H]- corre-
sponding to the molecular formulae C55H68N10O14FCl and
C55H67N10O14F2Cl. This indicated that hormaomycin analogs
carrying one and two fluorinated residues had been generated.
A third feeding experiment with para-fluorinated Phe resulted
in the isolation of 11 mg hormaomycins. By positive-ion ESI-
MS, a new ion at m/z = 1168 [M+Na]+ corresponding to a single
incorporated residue was detected, but not the ion of the doubly
modified analog. However, in contrast to the studies with o- and
m-fluorinated analogs, another new ion at m/z = 1137 [M+Na]+
was present, which was in agreement with a compound carrying
two carbons and four hydrogens less than hormaomycin.386 Chemistry & Biology 18, 381–391, March 25, 2011 ª2011 Elsevier Ltd All rights reservedMetabolites with the same mass were
also detected after incubations with
p-chloro-, p-bromo, and p-nitro-Phe. To
characterize the compound(s), peptides
from a fermentation with p-ClPhe were
purified byHPLC. This yielded, in addition
to authentic hormaomycin, the three
new derivatives hormaomycin J1-J3 (2-4)
at amounts of 1–2 mg. According to
HRMS data, hormaomycin J1 (2) and J2
(3) both had the molecular formula
C54H67N10O14Cl (m/z = 1137.44182 and
1137.44160, respectively, for [M+Na]+,
calcd. 1137.44190), which indicated the
absence of a methylene group. In agree-
ment, the NMR spectra were almost
identical to those of hormaomycin (Fig-
ure S2 and Table S2). Major differences
for 2 were missing resonances at dH =
1.39 and 3.68 and dC = 13.0, which corre-
spond to the methyl group of (b-Me)Phe I.
The proton spectrum also shows a
modified coupling pattern of the amino
acid a-proton (dH = 4.47), which results
from the presence of two methylene
instead of one methine proton at the
b-position (dH = 2.80 and 3.37). The
residue replacing (b-Me)Phe I is therefore
Phe, establishing a structure for 2 as
shown in Figure 1. In analogy, NMR
spectra for 3 lack the methyl signal of(b-Me)Phe II (dH = 1.29) and exhibit a new coupling of an amino
acid a-proton at dH = 4.61–4.66 to two b-methylene protons at
dH = 2.88 and 2.96, identifying this compound as a Phe analog
with an altered (b-Me)Phe II position. Compound 4 has the
molecular formula C53H65N10O14Cl (m/z = 1123.42646 for
[M+Na]+, 1123.42625 calcd.), which is two carbons and four
hydrogens less than for 1. The NMR spectra was of poor quality
due to the low available amounts, but clearly lacked signals for
the methyl group of both (b-Me)Phe units and contain two addi-
tional methylene coupling systems similar to those present in 2
and 3. Therefore, all (b-Me)Phe (8) residues in 4 should be
replaced by Phe. The fact that nor- and bisnor-hormaomycins
were produced instead of the expected analogs bearing halogen
or nitro was unexpected. One possible explanation is that the
403020100
RT [min]
E. coli pDF10 + L-DOPA 
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Figure 6. HPLC-MS Analysis of L-DOPA (9)
Cleavage by HrmF
The boxes show the UV and HRMS spectrum of
the cleavage product. HPLC traces at 413 nm
are shown for the HrmF product mixture and two
negative controls. E. coli pDF10 carries the hrmF
expression plasmid, E. coliBL21(DE3) is the empty
control strain. See also Figure S3.
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transferase HrmS or the aminotransferase. The A domains of the
8-specific modulesmight then accept and incorporate Phe as an
alternative substrate.
(4-Pe)Pro Biosynthesis
Our feeding studies suggested that the (4-Pe)Pro (7) moiety is
derived from L-Tyr (15) via a pathway related to those found in
lincomycin and pyrrolo[1,4]benzodiazepine (anthramycin, tom-
aymycin and sibiromycin) biosynthesis. In agreement, the hrm
cluster contains a set of genes hrmCDEFG that are similar to
counterparts in the gene clusters of these compounds (Fig-
ure 5C) (Hu et al., 2007; Li et al., 2009a, 2009b; Peschke et al.,
1995). The only characterized related proteins are LmbB2 and
LmbB1 of the lincomycin pathway. LmbB1, a homolog of
HrmF, is a dioxygenase that performs an extradiol cleavage of
L-DOPA (13) to the pyrroline intermediate 16 (Colabroy et al.,
2008; Neusser et al., 1998). Both enzymes belong the same
superfamily as the ring-cleaving dioxygenases but exhibit no
closer similarity to the classical extradiol cleavage enzymes
(Bugg and Winfield, 1998). It was also shown that LmbB1 and
the HrmE homolog LmbB2 jointly convert 15 to the same product
(Neusser et al., 1998). LmbB2 and HrmE could therefore be
L-tyrosine hydroxylases. The other steps are poorly understood.
HrmC exhibits the highest similarity to putative SAM-dependent
methyltransferases encoded by the lincomycin, anthramycin,
and sibiromycin clusters, which likely attach the terminal methyl
function. Such a role for HrmC is also in agreement with our
feeding studies using L-[methyl-13C]Met. HrmD resembles
LmbY, a putative coenzyme F420-dependent oxidoreductase. A
mutant strain of the lincomycin producer impaired in formation
of the F420 chromophore accumulated the diene 18, suggesting
that LmbY might reduce the diene system (Kuo et al., 1992).
Since 18 already carries the terminal methyl group, cleavage
and methylation should occur earlier in the pathway. Surpris-
ingly, with the exception of the putative g-glutamyl transpepti-Chemistry & Biology 18, 381–391, March 25, 2011dase HrmG, which should be involved in
biosynthesis of the F420 cofactor, no other
homologs in the related pathways were
found. In particular, among the gene clus-
ters generating (4-Pe)Pro-related moie-
ties, the hrm system is the only one
that lacks an lmbX-homolog, which has
been proposed to be responsible for
cleavage of the common precursor 16
(Li et al., 2009a, 2009b). LmbX was
recently demonstrated to be essential in
the biosynthesis of the lincomycin propyl-
proline (19) unit (Ulanova et al., 2010).We initially suspected that a part of the hormaomycin pathway
is encoded on an additional, unclustered section of the
S. griseoflavus genome. To search for hrm genes that might
have been missed, the genomic DNA of the hormaomycin
producer was tested with degenerate primers derived from an
alignment of lmbX with all known homologs (sibS, tomK, and
anthramycin ORF15). However, no PCR product was observed.
Likewise, extensive attempts to detect an lmbX-like gene by
Southern hybridization using an lmbX-derived probe together
with either genomic DNA or the arrayed library were unsuccess-
ful. In the later course of our studies, a draft genome sequence of
S. griseoflavus Tu¨4000, which is identical to the hormaomycin
producer W-384 studied in this work (M. Fischbach, personal
communication), became available in GenBank. Inspection of
the genome revealed the presence of a locus highly similar to
the hrm cluster. A major difference was found in the NRPS
region, which consisted of only a single gene encoding five
modules instead of two genes for seven modules. This architec-
ture might be an artifact caused by the automated assembly
of the highly repetitive NRPS sequences or the result of natural
recombination. In agreement with the PCR and Southern
studies, the draft genome lacked an lmbX homolog. The
data therefore indicate that such an enzyme is not needed for
(4-Pe)Pro biosynthesis and that the terminal two-carbon unit of
16 is cleaved off by another enzyme. To test the possibility that
HrmF might perform this reaction in addition to L-DOPA (13)
cleavage, it was heterologously expressed in E. coli (Figure S3).
After cloning the gene into the vector pHIS8, cultures of E. coli
carrying the plasmid turned bright yellow after incubation with
13, while the color change was not observed in control experi-
ments in the absence of hrmF or 13 (Figure S3A). Analysis of
the yellow product by HPLC-high resolution MS (HRMS) (Fig-
ure 6; Figure S3B) revealed the presence of a compound with
the same UV spectrum as the previously reported LmbB1
cleavage product (Neusser et al., 1998). Moreover, theMS spec-
trum showed two ions atm/z = 212.0551 and 234.0382 that wereª2011 Elsevier Ltd All rights reserved 387
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a compound with the molecular formula C9H9NO5. Since this
composition preciselymatches to 16 and there was no indication
for the formation of a downstream cleavage product, such as 17,
a role of HrmF in further cleavage of 16 is unlikely. To further
characterize the HrmF-catalyzed reaction in vitro, the His8-
tagged protein was prepared (Figure S3C) and assayed in vitro
with 13 in the presence of ascorbic acid. For a kinetic analysis,
formation of the yellow cleavage product at different concentra-
tion of 13 was monitored at 414 nm (Figure S3D). The data
support a KM of 3.35 mM and a kcat of 57.8 min
-1, which corre-
spond to a significantly higher catalytic efficiency than displayed
by the homolog LmbB1 (KM = 38 mM, kcat = 4.2 min
-1) (Colabroy
et al., 2008).
(3-Ncp)Ala Biosynthesis
Given the putative gene assignments already made, surprisingly
few genes remain that might be attributed to (3-Ncp)Ala (5)
production. Incorporation experiments suggested that this
amino acid is generated from L-lysine via 4-hydroxylysine or its
lactone, leading to the proposal that cyclopropanation is
achieved by intramolecular nucleophilic substitution at the acti-
vated position 4 (Figure 5D) (Brandl et al., 2004). The only protein
with a predictable role in lysine metabolism is HrmT, which
displays high similarity to diaminopimelate epimerases cata-
lyzing the penultimate step in lysine biosynthesis (Scapin and
Blanchard, 1998). HrmT could therefore play a role in diverting
lysine precursors from primary metabolism to hormaomycin
biosynthesis. Of the remaining unassigned genes, hrmR is highly
similar to the mbtH gene family, members of which are associ-
ated with many NRPS pathways and can positively influence
amino acid activation (Drake et al., 2007; Felnagle et al., 2010;
Lautru et al., 2007; Stegmann et al., 2006; Wolpert et al.,
2007). A role in 5 formation is therefore unlikely. This leaves
only two genes, hrmI and hrmJ, as candidates. Bioinformatic
analyses provided no insights into their possible function, since
only a few uncharacterized relatives exist. No obvious homologs
of enzymes that were previously shown to be involved in cyclo-
propanation, such as a-ketoglutarate/Fe2+-dependent halo-
genases or a CmaC-related protein (Gu et al., 2009; Kelly
et al., 2007; Vaillancourt et al., 2005) were found encoded in
the hrm cluster or elsewhere in the genome. Functional studies
on hrmI and hrmJ are currently under way to examine their role
in hormaomycin biosynthesis.
SIGNIFICANCE
The bacterial depsipeptide hormaomycin from Strepto-
myces griseoflavusW-384 is unique among pro- and eukary-
otic hormones both in terms of its complex, highly unusual
structure and its dual activity as an inducing agent and
potent narrow-spectrum antibiotic. Isolation of the biosyn-
thetic gene cluster reveals a complex evolutionary history
of the pathway consisting of DNA duplication and recombi-
nation events that resulted in switches of adenylation
domain selectivity. Extensive feeding and enzymatic
studies were conducted that yielded several novel hormao-
mycins and provide insights into the formation of most of
the amino acids. The unique 3-propenylproline moiety is388 Chemistry & Biology 18, 381–391, March 25, 2011 ª2011 Elseviegenerated from L-tyrosine via a pathway involving cleavage
of L-DOPA, while the unprecedented chlorinated pyrrole
derivative Chpca is generated from proline. The study
provides the foundation for engineering experiments to
generate further hormaomycin analogs that may aid in the
identification and exploitation of bacterial signaling path-
ways and the as-yet unknownmolecular target in antibiosis.
EXPERIMENTAL PROCEDURES
General
One- and two-dimensional 1H- and 13C-NMR spectra were recorded on a
Varian Inova-600, Varian Inova-500, Varian Mercury-300, Varian Unity-300
and Bruker AMX 300 spectrometer in CDCl3 using the solvent signals as the
reference. MALDI-TOF-MS spectra were recorded on a Bruker autoflex II
TOF/TOF time of flight mass spectrometer. Electrospray high-resolution
mass spectra and collision-induced dissociation (CID) MSn spectra were
recorded on a Bruker micrOTOF-Q time-of-flight mass spectrometer, and
Bruker Apex-Q III and Bruker APEX IV Fourier-transform ion cyclotron-reso-
nance (FT-ICR) mass spectrometers with 7.05 T magnets. Instruments were
equipped with an Apollo electrospray ion source. Analyte solutions in acetoni-
trile were introduced into the ion source with a syringe pump (Cole-Parmers
Instruments, Series 74900) at flow rates of 3 to 4 ml min-1 or with an Agilent
HPLC pump (1200 series) at a flow rate of 50 ml/min. Thin layer chromatog-
raphy was performed on silica gel 60 F254 plates (layer thickness 0.2 mm,
Merck). Analytical HPLC separation was performed on a PerfectChrom 100
C18 reverse-phase analytic column (250 3 4 mm, 5 mm) with a flow rate
1 ml min-1. The compounds were detected with a Jasco MD-2015 PDA
detector at the wavelengths 280 or 413 nm.
Bacterial Strains and Culture Conditions
E. coli BL21(DE3) served as the host strain for heterologous expression exper-
iments. S. griseoflavus W-384 was grown on M2+ plates or in NM6 or NM10
liquid medium (Brandl et al., 2004). E. coli strain XL1 blue served as host for
routine subcloning. For intergeneric conjugation E. coli ET12567 containing
the RP4 derivative pUZ8002 was used (Kieser et al., 2000). E. coli strains
were grown in LBmedium supplemented with ampicillin (100 mg ml-1), or apra-
mycin (50 mg ml-1), or streptomycin (50 mg ml-1), or kanamycin (50 mg ml-1) for
selection. For overexpression, 1 liter cultures of E. coli BL21(DE3) containing
the expression plasmid were grown to an OD600 of 0.6 (37
C, 200rpm), IPTG
was then added to a final concentration of 1 mM and cells were grown for
approximately 20 hr at 16C.
Plasmids and General DNA Procedures
DNA isolation, plasmid preparation, restriction digests, gel electrophoresis,
and ligation reactions were conducted according to standard methods (Kieser
et al., 2000; Sambrook and Russel, 2001). pBluescript II SK(-) was the routine
vector for subcloning and preparation of DNA templates for sequencing. For
overexpression and purification, hrm Genes were cloned into the expression
vector pHIS8 (Jez et al., 2000).
Purification of Proteins
The cells were harvested by centrifugation (6000 rpm, 30 min) at 4C and
resuspended in lysis buffer (100 mM Tris-HCl [pH 7.5]) containing 0.5 M
NaCl and 10mM imidazole. The cell suspension was kept on ice and sonicated
in 10 s intervals. The cell debris was removed by centrifugation at 11,000 rpm
for 30 min at 4C. The supernatant was incubated with 1.5 ml Ni-NTA agarose
(QIAGEN) for 1 hr at 4C andwashed with 5ml lysis buffer. His-tagged proteins
were eluted in 1 ml fractions with lysis buffer containing rising imidazole
concentrations (50–300 mM). Protein concentrations were determined by
Bradford (RotiNanoquant, Roth) and protein containing fractions were pooled
and desalted using HiTrap Columns (GE).
Isolation and Sequencing of the hrm Genes
A library of Streptomyces griseoflavus W-384 DNA in E. coli EPI305 was con-
structed in the cosmid vector pWEB (Epicenter). 2000 clones were picked into
96-well microtiter plates. A 1200 bp fragment encoding an A domain of ther Ltd All rights reserved
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gift of D. Schwartz, Esslingen). A 32P-labeled hybridization probe prepared
from this fragment served to identify positive cosmids. The positives were
further screened with a 32P-labeled probe prepared from the gene cloN4 of
the clorobiocin cluster (kind gift of L. Heide, Tu¨bingen). The two positive
cosmids pHR6G10 and pHR1F4 were sonicated, end-repaired by BAL-31
and Klenow fragment and size-fractionated by gel electrophoresis to obtain
fragments of 1–2 kb lengths. These were ligated into the EcoRV site of
pBluescript II SK(-) and end sequenced with the BigDye Terminator Ready
Mix (Applied Biosystems) and an ABI3700 sequencer (Applied Biosystems).
Remaining gaps were filled by targeted subcloning and the use of specific
primers. For genome screening of lmbX homologs, degenerate primers
hrmXfor (50-CAR GAR TGY GGN DSN MGN-30 ) and hrmXrev (50-NGW HGC
RCA NGC NGG RTC-30) were used. The lmbX gene fragment was amplified
by PCR from the genomic DNA of lincomycin producer Streptomyces
lincolnensis NRRL 2936 using primers lmbXfor(50-GGA ATT CAT GAT CGT
GGT CCC-30 ) and lmbXrev(50-CCC AAG CTT CTA CAC GGA AGC-30). PCR
products were ligated into pBluescript SK(+) to get pXC7 and end sequenced.
The lmbX gene fragment was digested with HindIII and EcoRI from pXC7
and labeled by DIG-High Prime DNA Labeling Kit as a probe to detect a
possible lmbX homolog in either the genomic DNA or the arrayed library by
Southern blot.
Kinetic Characterization of HrmF
The gene hrmF was amplified by PCR using primers hrmFfor (50-GGA TCC
CCC GAG AAC CTC G-30) and hrmFrev (50-AAG CTT TCA CCC CGC CGA
CT-30). PCR products were ligated into pBluescript SK(+) via TA cloning
(Marchuk et al., 1991) to give pDF017. After restriction digest with BamHI
and HindIII the genes were ligated into the same restriction sites of the expres-
sion vector pHIS8 to give pDF024. The overexpressed protein was purified
with Ni-NTA affinity chromatography. Desalted HrmF in 100 mM phosphate
buffer (pH 8) was treated with L-DOPA in different concentrations. A typical
assay, adapted from the literature (Colabroy et al., 2008), consisted of 25 ml
enzyme (1.3 mM), 10 mML-DOPA, and 10 mMascorbic acid in 500 ml phosphate
buffer (100 mM [pH 8]). The enzymatic activity wasmonitored by measuring the
absorbance increase at 414 nm resulting from the formation of the yellow
cleavage product (3 = 20.300 ± 890 M-1 cm-1) for 30 min using a BioMate 3
photometer (Thermo). Experiments were performed in triplicate. For determi-
nation of kinetic parameters initial rates were plotted versus the substrate
concentration and fitted to the Michaelis-Menten equation with the Hanes-
Woolf Plot.
Mass-Exchange Based Adenylation Assay of the HrmP1 A-Domain
The A domain region of the module HrmP1 was amplified by PCR using
primers hrmP1for (50-AAA GAA TTC GGC CGG CTG GAC GTC GT-30 ) and
hrmP1rev (50-AAA AAG CTT TCA CTC CTC CTG CGC GGT ACG CG-30).
PCR products were ligated into pBluescript SK(+) with TA cloning. After
restriction digest with EcoRI and HindIII, the insert was ligated into the same
sites of the expression vector pHIS8, and the resulting plasmid was trans-
formed into E. coli BL21(DE3). The overexpressed protein was purified by
Ni-NTA affinity chromatography. The desalted enzyme in Tris HCl (50 mM,
pH 7.5) was incubated with labeled [g-18O4]-ATP, various test substrates,
MgCl2 and pyrophosphate as previously described (Phelan et al., 2009). The
mass exchange of 8 D was observed by MALDI-TOF-MS.
Hormaomycin J1 (2)
1HNMR data, see Table S2. 13C NMR (150.8MHz, CDCl3): d = 10.6 (+, C-5, Ile),
13.3 [+, C-30, (4-Pe)Pro], 14.8 (+, C-10, Ile), 17.0 (+, C-4, a-Thr), 17.3 [–, C-30,
(3-Ncp)Ala I], 17.9 [+, C-4, (b-Me)Phe], 20.0 [+, C-10, (3-Ncp)Ala I], 21.6
[+, C-10, (3-Ncp)Ala II], 25.1 (–, C-3, Ile), 33.4 [–, C-3, (3-Ncp)Ala I], 34.8
[–, C-3, (3-Ncp)Ala II], 35.6 [–, C-3, (4-Pe)Pro], 36.6 [+, C-4, (4-Pe)Pro], 37.6
(+, C-3, Ile), 38.2 [–, C-3, Phe], 42.0 [+, C-3, (b-Me)Phe], 51.4 [+, C-2,
(3-Ncp)Ala II], 51.6 [+, C-2, (3-Ncp)Ala I], 52.8 [–, C-5, (4-Pe)Pro], 54.7
(+, C-2, Ile), 55.1 (+, C-2, a-Thr), 56.2 (+,C-2, Phe], 58.2 [+, C-20, (3-Ncp)Ala I],
59.2 [+, C-20, (3-Ncp)Ala II], 59.9 [+, C-2, (b-Me)Phe], 61.4 [+, C-2, (4-Pe)Pro],
69.2 (+, C-3, a-Thr), 103.8 (+, C-4, Chpca), 110.6 (+, C-3, Chpca), 120.1 (Cquat,
C-2,Chpca), 120.5 (Cquat, C-5, Chpca), 127.2, 127.29, 127.33, 127.67, 127.73,
128.6, 128.8, 128.9 [+, C-10, C-20, (4-Pe)Pro, Ar-C], 141.6, 141.8 (Cquat, Ar-C),Chemistry & Biology 18, 3159.3 (Cquat, C-1, Chpca), 168.8, 169.5, 169.9, 170.9, 171.3, 171.6, 171.9
(Cquat, C-1). HRMS: 1137.44182, calcd. 1137.44190 for [M+Na]
+, 1132.48710,
calcd. 1132.48650 for [M+NH4]
+, 1115.45963, calcd. 1115.45995 for [M+H]+.
UV (MeOH) lmax (lg 3) = 269 (4.00) nm; (MeOH, HCl) 267 (3.92) nm; (MeOH,
NaOH) 273 (3.84) nm. CD (MeOH): lmax ([Q]
20) = 275 (+6400), 221 (–40700),
208 (+2500) nm. [a] = +4 (c = 0.1, MeOH). IR (KBr): n = 3416 (br), 2940,
2353, 1649, 1534 1369, 1184, 1064 cm-1.Hormaomycin J2 (3)
1H NMR data, see Table S2. Due to the small amounts of produced substance
no 13C NMR spectrum could be obtained. HRMS: 1137.44160, calcd.
1137.44190 for [M+Na]+, 1132.48664, calcd. 1132.48650 for [M+NH4]
+,
1115.45946, calcd. 1115.45995 for [M+H]+. UV (MeOH) lmax (lg 3) = 278
(4.07) nm; (MeOH, HCl) 271 (3.48) nm; (MeOH, NaOH) 283 (3.80) nm. CD
(MeOH): lmax ([Q]
20) = 280 (+22800), 226 (–50300), 207 (+8000) nm. [a] =
8 (c = 0.1, MeOH). IR (KBr): n = 3423, 2929, 1741 (sh), 1630, 1543, 1445,
1377, 1255, 1178, 1129, 1075, 1025 (sh) cm-1.Hormaomycin J3 (4)
HRMS: 1123.42646, calcd. 1123.42625 for [M+Na]+, 1118.47005, calcd.
1118.47085 for [M+NH4]
+, 1101.44438, calcd. 1101.44430 for [M+H]+. UV
(MeOH) lmax (lg 3) = 279 (4.06) nm; (MeOH, HCl) 270 (3.89) nm; (MeOH,
NaOH) 282 (3.97) nm. CD (MeOH): lmax ([Q]
20) = 281 (+10500), 223 (–49500),
207 (+4200) nm. [a] = 8 (c = 0.1, MeOH). IR (KBr): n = 3419 (br), 2941,
2356, 1649, 1536, 1442, 1387, 1442, 1387, 1264, 1185, 1028 cm-1. Due to
the small amounts of substance produced, the NMR spectrum was of poor
quality, and no data are given.ACCESSION NUMBER
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